Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
US Army
Johnson and Johnson
Chinese Patent Office
McKesson

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Oprelvekin

« Back to Dashboard

US Patents for Oprelvekin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oprelvekin ➤ Try a Free Trial Compositions comprising serum albumin and p53 peptides fusion proteins University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Method of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Compositions and methods for improved delivery of hydrophobic agents Lipocine, Inc. (Salt Lake City, UT) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Method and system for use in treating a patient with an anticoagulant to optimize therapy and prevent an adverse drug response Dimensional Dosing Systems, Inc. (Wexford, PA) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Polysaccharides for pulmonary delivery of active agents Momenta Pharmaceuticals, Inc. (Cambridge, MA) ➤ Try a Free Trial
Oprelvekin ➤ Try a Free Trial Polymeric micelles for drug delivery Intezyne Technologies, Inc. (Tampa, FL) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Oprelvekin

Drugname Country Document Number Estimated Expiration Related US Patent
Oprelvekin European Patent Office 3220953 2034-11-21 ➤ Try a Free Trial
Oprelvekin World Intellectual Property Organization (WIPO) 2016081897 2034-11-21 ➤ Try a Free Trial
Oprelvekin China 105407920 2033-05-03 ➤ Try a Free Trial
Oprelvekin European Patent Office 2991677 2033-05-03 ➤ Try a Free Trial
Oprelvekin Hong Kong 1222564 2033-05-03 ➤ Try a Free Trial
Oprelvekin Japan 2016529204 2033-05-03 ➤ Try a Free Trial
Oprelvekin World Intellectual Property Organization (WIPO) 2014178878 2033-05-03 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
US Army
Cipla
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.